Mastocytosis: Reactive or neoplastic?

被引:23
作者
Krober, SM
Horny, HP
Ruck, P
Kammerer, U
Geiselhart, A
Handgretinger, R
Greisser, H
Menke, DM
Kaiserling, E
机构
[1] UNIV TUBINGEN,INST PATHOL,DEPT PATHOL,D-72076 TUBINGEN,GERMANY
[2] UNIV WURZBURG,DEPT GYNAECOL,D-97070 WURZBURG,GERMANY
[3] UNIV WURZBURG,DEPT PATHOL,D-97070 WURZBURG,GERMANY
[4] MAYO CLIN JACKSONVILLE,JACKSONVILLE,FL 32224
[5] UNIV TUBINGEN,INST PATHOL,DEPT PAEDIAT,D-72076 TUBINGEN,GERMANY
关键词
HUMARA; mastocytosis; clonality; polymerase chain reaction;
D O I
10.1136/jcp.50.6.525
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Mast cells are now known to derive from CD34(+) haemopoietic stem cells in the bone marrow. However, it has not yet been established whether the various types of mastocytosis, which involve tumour-like proliferation of mast cells, are true neoplastic disorders or reactive/hyperplastic conditions. In this study tissue specimens (five bone marrow, two spleen, one skin) from female patients with histologically confirmed mastocytosis were investigated with a recently developed polymerase chain reaction assay for the determination of clonality of female cells using the human androgen receptor gene (HUMARA). Mast cells purified to near homogeneity from hysterectomy specimens served as a control. The findings in bone marrow and skin either were not reproducible, or indicated polyclonality. How both ever, both spleen specimens exhibited monoclonality. In addition, DNA analysis by flow cytometry was performed and revealed a diploid chromosome content with proliferation indices of under 8% in all the specimens. This is the first molecular biological study to indicate that mastocytosis is indeed neoplastic in nature.
引用
收藏
页码:525 / 527
页数:3
相关论文
共 10 条
[1]  
ALLEN RC, 1992, AM J HUM GENET, V51, P1229
[2]  
BUSQUE L, 1993, BLOOD, V82, P337
[3]   METHOD FOR ANALYSIS OF CELLULAR DNA CONTENT OF PARAFFIN-EMBEDDED PATHOLOGICAL MATERIAL USING FLOW-CYTOMETRY [J].
HEDLEY, DW ;
FRIEDLANDER, ML ;
TAYLOR, IW ;
RUGG, CA ;
MUSGROVE, EA .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1983, 31 (11) :1333-1335
[4]  
KIRSHENBAUM AS, 1991, J IMMUNOL, V146, P1410
[5]   Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: Establishment of clonality in a human mast cell neoplasm [J].
Longley, BJ ;
Tyrrell, L ;
Lu, SZ ;
Ma, YS ;
Langley, K ;
Ding, TG ;
Duffy, T ;
Jacobs, P ;
Tang, LH ;
Modlin, I .
NATURE GENETICS, 1996, 12 (03) :312-314
[6]  
MASHAL RD, 1993, CANCER RES, V53, P4676
[7]   HIGH-GRADIENT MAGNETIC CELL-SEPARATION WITH MACS [J].
MILTENYI, S ;
MULLER, W ;
WEICHEL, W ;
RADBRUCH, A .
CYTOMETRY, 1990, 11 (02) :231-238
[8]  
MUTTER GL, 1995, AM J PATHOL, V146, P501
[9]   IDENTIFICATION OF A POINT MUTATION IN THE CATALYTIC DOMAIN OF THE PROTOONCOGENE C-KIT IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS OF PATIENTS WHO HAVE MASTOCYTOSIS WITH AN ASSOCIATED HEMATOLOGIC DISORDER [J].
NAGATA, H ;
WOROBEC, AS ;
OH, CK ;
CHOWDHURY, BA ;
TANNENBAUM, S ;
SUZUKI, Y ;
METCALFE, DD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (23) :10560-10564
[10]   LANGERHANS-CELL HISTIOCYTOSIS (HISTIOCYTOSIS-X) - A CLONAL PROLIFERATIVE DISEASE [J].
WILLMAN, CL ;
BUSQUE, L ;
GRIFFITH, BB ;
FAVARA, BE ;
MCCLAIN, KL ;
DUNCAN, MH ;
GILLILAND, DG .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (03) :154-160